Journal article
Methotrexate and Lung Disease in Rheumatoid Arthritis: A Meta‐Analysis of Randomized Controlled Trials
Abstract
OBJECTIVE: Methotrexate has shown efficacy for the treatment of several diseases, especially rheumatoid arthritis (RA). Methotrexate has also been implicated as a causative agent in interstitial lung disease. Patients with RA may develop pulmonary manifestations of their disease and are at increased risk of respiratory infection. The aim of this study was to evaluate the relative risk (RR) of pulmonary disease among patients with RA treated …
Authors
Conway R; Low C; Coughlan RJ; O'Donnell MJ; Carey JJ
Journal
Arthritis & Rheumatology, Vol. 66, No. 4, pp. 803–812
Publisher
Wiley
Publication Date
April 2014
DOI
10.1002/art.38322
ISSN
2326-5191